June Bray's Insider Trades & SAST Disclosures

June Bray's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Quince Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 27,000 27,000 - - Director Stock Option (Right to Buy)
Quince Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 30,282 30,282 - - Director Stock Option (right to buy)
BioXcel Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 17,000 17,000 - - Stock Option (Right to Buy)
Quince Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 27,000 27,000 - - Employee Stock Option (right to buy)
BioXcel Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 17,000 17,000 - - Stock Option (Right to Buy)
Quince Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2023 27,000 27,000 - - Stock Option (right to buy)
Quince Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 54,000 54,000 - - Stock Option (right to buy)
BioXcel Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 17,000 17,000 - - Stock Option (Right to Buy)
BioXcel Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
BioXcel Therapeutics Inc
June Bray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2021 4,167 4,167 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades